# Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

> **NCT05944016** · PHASE3 · RECRUITING · sponsor: **University Hospital Goettingen** · enrollment: 102 (estimated)

## Conditions studied

- Chronic Kidney Failure in Children and Young Adults

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05944016
- **Lead sponsor:** University Hospital Goettingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-25
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944016, "Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05944016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*